SCHEMBL831132

SCHEMBL831132

CS(=O)(=O)c1cc2ccccc2oc1=O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.70
CA9 Q16790 4/20 0.70
CA1 P00915 3/20 0.70
CA2 P00918 3/20 0.70
KDM4E B2RXH2 6/20 0.63
ALDH1A1 P00352 5/20 0.63
NPSR1 Q6W5P4 1/20 0.63
RXFP1 Q9HBX9 1/20 0.63
HPGD P15428 4/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
TYR P14679 1/20 0.53
DAO P14920 1/20 0.53
AKR1B1 P15121 1/20 0.53
POLB P06746 1/20 0.53
MAOB P27338 6/20 0.51
CYP1A2 P05177 2/20 0.51
NT5E P21589 2/20 0.51
MAOA P21397 3/20 0.50
RAB9A P51151 1/20 0.50
CA3 P07451 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluorobenzene SCHEMBL28023117 0.91 CA12 (0.59) CA12CA9CA1CA2KDM4E
Chlorobenzene SCHEMBL28022498 0.91 CA12 (0.59) CA12CA9CA1CA2KDM4E
Bromobenzene SCHEMBL28022511 0.91 CA12 (0.59) CA12CA9CA1CA2KDM4E
Anisole SCHEMBL28023120 0.88 KDM4E (0.57) CA12CA9CA1CA2KDM4E
SCHEMBL830181 0.85 CA12 (0.74) CA12CA9CA1CA2KDM4E
SCHEMBL830136 0.82 CA1 (1.00) CA12CA9CA1CA2KDM4E
SCHEMBL1047082 0.82 CA12 (0.70) CA12CA9CA1CA2KDM4E
SCHEMBL22273887 0.82 CA12 (0.70) CA12CA9CA1CA2KDM4E
SCHEMBL20435590 0.79 KDM4E (0.78) CA12CA9CA1CA2KDM4E
SCHEMBL10533634 0.78 ERAP1 (0.65) CA12CA9CA1CA2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143428-B2 Heteroaryl sulfones and sulfonamides and therapeutic uses thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2012-03-27 US disclosed
US-20070232649-A1 Heteroaryl Sulfones and Sulfonamides and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2007-10-04 US disclosed
EP-1765804-A2 HETEROARYL SULFONES AND SULFONAMIDES AND THERAPEUTIC USES THEREOF Temple University of the Commonwealth System of Higher Education (US) 2007-03-28 EP disclosed
WO-2005123077-A2 HETEROARYL SULFONES AND SULFONAMIDES AND THERAPEUTIC USES THEREOF TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2005-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232649-A1 Heteroaryl Sulfones and Sulfonamides and Therapeutic Uses Thereof SULT1E1, STS, CCNE1 CA12 2448/4885CA9 1884/4885CA1 3859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.